Formulary Search - PAD Formulary

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results

Records returned : 26.

Guideline Profile : Menopausal disorders
Brand names include : Mirena, Elleste Solo, Premarin, Bedol, Zumenon, Progynova, Oestrogel, Sandrena, Evorel, Elleste Solo MX, Estraderm MX, Estradot, Progynova TS, Elleste Duet, Clinorette, Novofem, Trisequens, Femoston, Tridestra, Evorel Sequi, Evorel Conti, Femoston Conti, Kliovance, Kliofem, Premique, Elleste Duet Conti, Indivina, Zoely, Qlaira, Livial, Duavive, Provera, Climanor, Utrogestan, Ovestin, Vagifem, Estring, Blissel, Imvaggis, Intrarosa, Senshio
Clonidine - Menopausal disorders
Conjugated oestrogens - Menopausal disorders
Brand names include : Premarin
Conjugated oestrogens with medroxyprogesterone - Menopausal disorders
Brand names include : Premique Low Dose
Drospirenone - Menopausal disorders
Brand names include : Slynd
Duavive - Menopausal disorders
Brand names include : 0.45 mg conjugated oestrogens/20 mg bazedoxifene
Estradiol - Menopausal disorders
Brand names include : Elleste Solo, Estraderm MX patch, Estradot Patch, Evorel Patch, FemSeven Patch, Lenzetto spray, Oestrogel, Progynova, Progynova TS patch, Sandrena gel, Zumenon
Estradiol (Transdermal spray) - Menopausal disorders
Brand names include : Lenzetto
Estradiol with dydrogesterone - Menopausal disorders
Brand names include : Femoston, Femoston Conti
Estradiol with levonorgestrel - Menopausal disorders
Brand names include : Femseven Conti
Estradiol with medroxyprogesterone - Menopausal disorders
Brand names include : Tridestra, Indivina
Estradiol with norethisterone - Menopausal disorders
Brand names include : Evorel Sequi, Elleste Duet, Novofem, Trisequens, Elleste Duet Conti, Evorel Conti, Kliofem, Kliovance
Estradiol with progesterone - Menopausal disorders
Brand names include : Bijuve
Ethinylestradiol - Menopausal disorders
Brand names include : oestrogen , Menopause, hot sweats, mood swings, anxiety, weight gain, oral tablet, Synthetic oestrogens, menopausal symptoms, early ovarian failure, HRT, hormone replacement therapy
HRT - Gabapentinoids - Menopausal disorders
Brand names include : Neurontin, lyrica
HRT continuous combined - Menopausal disorders
Brand names include : Femoston Conti, Indivina, Elleste Duet Conti, Kliofem, Premique low dose, Evorel Conti, FemSeven Conti, Kliovance
HRT Oestrogen only - Menopausal disorders
Brand names include : conjugated oestrogen, Estradiol, valerate, Menopause, hot sweats, mood swings, anxiety, weight gain, peri menopausal, patch, oral tablet, transdermal, gel, vaginal ring, pessary, pessaries, unopposed, hormone replacement therapy, urogenital atrophy, estrogen
HRT sequential combined - Menopausal disorders
Brand names include : medroxyprogesterone, Estradiol, Norethisterone,dydrogesterone, Menopause, hot sweats, mood swings, anxiety, weight gain, peri menopausal, patch, oral tablet, transdermal, hormone replacement therapy
Levonorgestrel intrauterine system - Menopausal disorders
Brand names include : Mirena
Medroxyprogesterone acetate - Menopausal disorders
Brand names include : Provera
Non-Hormonal lubricants - Menopausal disorders
Brand names include : Replens MD, Sylk, Yes
Paroxetine - Menopausal disorders
Brand names include : Seroxat
Progesterone - Menopausal disorders
Brand names include : Gepretix, Utrogestan
St Johns Wort - Menopausal disorders
Tibolone - Menopausal disorders
Brand names include : hormone replacement therapy, HRT, menopause, gonadomimetics, menopausal symptoms
Venlafaxine - Menopausal disorders
Brand names include : Efexor

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

ICB

Treatment commissioned by the ICB

BlueTeq

BlueTeq form to be completed

NICE

Traffic Light Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Black

Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.

Amber Star

Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)

See Below

Please add a description.

N/A

Please add a description.

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green - Black

Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.

See narrative

See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)

Do not initiate in new patients

These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)